Shares of Cara Therapeutics (NASDAQ:CARA) fell by 27.8% less than at 10:54 on Tuesday. The big drop came after the pharmacist announced the results of a phase 2 clinical trial that evaluated oral Korsuva in the treatment of patients with chronic kidney disease (CKD) with moderate to severe (itching) itching. Cara said oral Korsuva reached …
Why Cara Therapeutics Stock Dropped Today Read More »
from
https://alphabetastock.com/2019/12/05/why-cara-therapeutics-stock-dropped-today/
No comments:
Post a Comment